Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mass Balance and Absolute Bioavailability Trial of cebranopadol in Healthy Subjects

Trial Profile

Mass Balance and Absolute Bioavailability Trial of cebranopadol in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs Cebranopadol (Primary)
  • Indications Back pain; Cancer pain; Diabetic neuropathies; Musculoskeletal pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Jul 2017 New trial record
    • 16 Jun 2017 Results assessing basic PK properties of cebranopadol by means of noncompartmental methods in six phase I clinical trials in healthy subjects published in the Clinical Pharmacokinetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top